Phase III trial of methotrexate

High-dose methotrexate therapy significantly improved survival of ...

We herein conducted a randomized phase III trial comparing Hd-MTX therapy with intermediate-dose (Id)-MTX therapy. This study was registered ...

Randomized phase III trial of high-dose-intensity methotrexate ...

PURPOSE: This randomized trial evaluated antitumor activity of and survival asociated with high-dose-intensity chemotherapy with methotrexate, ...

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf ...

FK506 (tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine ...

... Phase III Study', Journal of Clinical Oncology, vol. 41, no. 23, pp. 3881-3890. https://doi.org/10.1200/JCO.22.02763. Gemcitabine and ...

Randomized phase III trial of dose-dense methotrexate, vinblastine ...

The primary endpoint was the progression-free survival at 3 years. Secondary endpoints included toxicity, pathological responses and overall survival. Results

Phase III Study Comparing Tnfr - Fc to Methotrexatext in Rheumatoid ...

This is a double-blind, randomized multicenter Phase III study comparing TNFR:Fc 10mg and 25mg to methotrexate (MTX) (7.5mg to 20mg) in MTX naive patients ...

A Study Assessing the Efficacy and Safety of SM03 in Patients With ...

To demonstrate that SM03 added to methotrexate (MTX) ... Clinical Study ID. NCT04312815. SM03-RA-III-V4.0. Ages 18-70; All Genders. Study Summary.

Bimzelx, INN-bimekizumab - European Medicines Agency

Bimzelx, alone or in combination with methotrexate ... Neutropenia was observed with bimekizumab in Phase III clinical studies in plaque psoriasis ...

Upadacitinib - Wikipedia

6.1.3 Phase III studies. 6.1.3.1 SELECT-COMPARE; 6.1.3.2 SELECT-CHOICE. 7 ... Trial 2 enrolled participants in whom methotrexate did not work well.

Alecensa, INN-alectinib - European Medicines Agency

When Alecensa is co-administered with BCRP substrates (e.g., methotrexate, mitoxantrone, topotecan ... In the phase III clinical trial BO28984, Grade 3 or 4 ...

New BIMZELX[®] (bimekizumab-bkzx) data at ACR Convergence ...

Psoriatic arthritis: Bimekizumab, alone or in combination with methotrexate ... phase 3 trial (BE OPTIMAL). Lancet. 2023;401(10370):25–37. Merola ...

Immune checkpoint inhibitor therapy as a neoadjuvant...

Most available literature consists of clinical investigations involving small sample, single-arm Phase II trials, with the primary endpoint ...

Tofacitinib - Wikipedia

In the phase III trials of tofacitinib among opportunistic infections, pulmonary tuberculosis (TB) was reported in 3 cases all of which were initially negative ...

Journal of the American Academy of Dermatology: Home Page

... phase 3 POETYK PSO-1 trial. Armstrong et al. Journal of the American Academy of Dermatology, Vol.88, No.1, p29-39. January 2023. Oral minoxidil treatment for ...

Sarcoidosis: Causes, Symptoms, Diagnosis & Treatment

Stage 3: Granulomas in your lungs only. Stage 4: X-rays show pulmonary ... Methotrexate is an immunosuppressant commonly used in sarcoidosis. Anti ...

American Academy of Dermatology

Find resources on membership, AAD meetings, education, practice management, publications, clinical care, and more. ... No thanks, I'll do this later ...

Folic Acid – Uses, Side Effects, and More - WebMD

Toxicity caused by the drug methotrexate. Taking folic acid by mouth ... phase of mania in bipolar disorder: a double-blind randomized controlled trial.

American Journal of Obstetrics & Gynecology: Home Page

... trial. Kytö et al. American Journal of Obstetrics & GynecologyVol. 231Issue 5 ... Most Cited (Previous 3 Years). Tweets by AJOG_thegray. Advertisement.

HTML Sitemap - Oncology News Central

FDA Expands Liquid Methotrexate Indication in ALL · Worrisome Data Drop ... Failed Phase 3 NSCLC Trial Yields Useful Data? Concierge Cancer Care: What ...

Cancer Outcomes | Moffitt

If you're looking for a clinical trial, Moffitt has more than 300 active trials. ... methotrexate, Methylprednisolone, Metoclopramide, MgSO4, Midostaurin ...